Rare Victory For Generic Drug Industry In Patent Ruling
The ruling clears the way for rival pharmaceutical company Andrx Corp.'s generic version of the drug.
According to the judgment filed in a U.S. District Court for the Eastern District of Missouri, the patents, which were due to expire in September 2007, are “invalid and unenforceable” because they constitute double-patenting.
Generic drug maker...
To view the full article, register now.